サンプル依頼リスト カート
  • English
市場調査レポート
商品コード
1226803

南米のマラリア治療市場の2028年までの予測- 地域別分析- 治療法別、薬剤タイプ別、投与経路別、流通チャネル別、エンドユーザー別

South America Malaria Treatment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Treatment, Drug Type, Route of Administration, Distribution Channel, and End User
出版日: | 発行: The Insight Partners | ページ情報: 英文 154 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
南米のマラリア治療市場の2028年までの予測- 地域別分析- 治療法別、薬剤タイプ別、投与経路別、流通チャネル別、エンドユーザー別
出版日: 2023年01月25日
発行: The Insight Partners
ページ情報: 英文 154 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

南米のマラリア治療市場は、2022年の7,179万米ドルから2028年には9,853万米ドルに成長すると予測されています。2022年から2028年までのCAGRは5.4%と推定されています。

迅速診断テストが南米のマラリア治療市場を牽引する

マラリアのRDTは、この病気の管理の質を向上させることができます。RDTは、低資源環境で実施される公衆衛生プログラムにとって、非常に安価で効果的であることが証明されています。RDTは、顕微鏡検査サービスへのアクセスが限られている遠隔地でも広く使用されています。その結果、マラリア用のRDTの需要が急速に高まっています。血液サンプル中のマラリア原虫の存在を検査するために、いくつかのRDTが開発されています。マラリアの感染を減らし、完全な撲滅を達成するためには、感染率の低い地域でマラリアを特定し、治療を成功させることが重要です。多くの企業が、高い感度を持つさまざまなRDTの開発に取り組んでいます。そのため、迅速診断テストの成長は、地域全体で南米のマラリア治療市場の成長を促進すると予想されます。

南米のマラリア治療市場の概要

南米のマラリア治療市場は、ブラジル、アルゼンチン、南米のその他の地域に分類されます。予測期間中、ブラジルは市場で大きなシェアを占めています。マラリアは、常にブラジルの公衆衛生上の主要な懸念事項となっています。ブラジルにおけるマラリアの初期の歴史とその対策は、アフリカ人が奴隷として強制移住させられたことと、欧州人の植民地化によって力を得てきました。移民たちは、ブラジルのさまざまな地域にマラリアを持ち込みました。ブラジルでは、マラリアは3種の原虫-P. vivax（登録症例の83.7％を占める）、P. falciparum（16.3％を引き起こす）、P. malariae（症例のごく一部）により引き起こされます。ブラジル政府は「マラリア撲滅計画」を策定し、2025年までにマラリアの地域別患者数を68,000人以下に、2030年までに死亡者数をゼロにし、2035年までにブラジル国内でマラリアを撲滅することを意図しています。ブラジルは、マラリア患者の多くが訪れるアマゾンの熱帯雨林を抱える国です。ブラジルにおける感染の約99.9%はアマゾン地域で、80%は33都市で発生しています。

2021年には137.8件以上の感染者が報告されています。ブラジル政府は、治療、害虫駆除、都市や州への技術支援に投資する一方、人材の育成も行っています。撲滅計画は、無料の診断と治療、診断と広範囲に及ぶ治療のための分散型アクションに基づき、オンライン情報システム、マルチセクターパートナーシップ、研究ネットワークを活用し、ブラジル統一保健システムを通じて活動する予定です。2019年10月30日、GSKブラジルとMMVは、ブラジル保健規制庁（AVINSA）が、16歳の患者およびP.vivax急性感染症に対してクロロキンを投与されている高齢者のマラリア原虫の内科治療用としてタフェノキンの単回投与をプロプライアタリーレビューで販売許可承認したと発表しました。GSKのブラジルにおける医薬品部門の社長であるホセ・カルロス・フェルナーは、同国におけるタフェノキンの承認は、マラリアなどの顧みられない病気との闘いにおいて重要な一歩であると述べています。これにより、ブラジルにおけるマラリア治療薬の需要が高まり、同疾患の撲滅に貢献することになります。このように、ブラジル政府による技術支援の高まりは、市場の成長を後押しすることができます。

南米のマラリア治療市場の収益と2028年までの予測（金額）

南米のマラリア治療市場のセグメンテーション

南米のマラリア治療市場は、治療法、薬剤タイプ、投与経路、流通チャネル、エンドユーザー、国に基づいてセグメント化されています。

治療法に基づき、南米のマラリア治療市場は、処方薬、ワクチン、診断テスト、その他に区分されます。2022年には、診断テストセグメントが最大の市場シェアを占めています。処方薬セグメントはさらに、リン酸クロロキン、アルテミシニンベースの併用療法（ACT）、アトバキン・プログアニル、ドキシサイクリン入り硫酸キニーネ（クアラキン）、リン酸プリマキン、その他に分類されます。

薬剤の種類に基づき、南米のマラリア治療市場はブランド品とジェネリック品に二分されます。2022年の市場シェアは、ジェネリックセグメントがより大きなシェアを占めています。

投与経路に基づき、南米のマラリア治療市場は、経口と非経口・静脈に二分されます。2022年には経口剤がより大きな市場シェアを占めています。

流通チャネルに基づき、南米のマラリア治療市場は、直接入札、病院薬局、小売薬局、オンライン薬局、およびその他に区分されます。2022年には、直接入札セグメントが最も大きな市場シェアを占めています。

エンドユーザーに基づき、南米のマラリア治療市場は、病院、専門クリニック、在宅ケア、その他に区分されます。病院セグメントが2022年に最大の市場シェアを占めました。

国別では、南米のマラリア治療市場は、ブラジル、アルゼンチン、南米のその他の地域に分類されています。地域別分析では、2022年に南米のその他の地域が市場を独占しているとされています。

AdvaCare Pharma USA LLC、Cipla Ltd、GSK Plc、Lupin Ltd、Novartis AG、Sanofi SA、Sun Pharmaceutical Industries Ltd、Viatris Inc、Zydus Healthcare Ltdは、南米のマラリア治療市場で活動している主要企業の1つです。

目次

第1章 イントロダクション

第2章 重要なポイント

第3章 調査手法

  • カバレッジ
  • 2次調査
  • 1次調査

第4章 マラリア治療市場-市場情勢

  • 南米のPEST分析
  • 専門家別オピニオン

第5章 南米のマラリア治療市場-主要市場力学

  • 市場促進要因
    • マラリアに関する意識向上のための政府および民間企業の取り組み
  • 市場抑制要因
    • 偽造抗マラリア薬とそれに続く薬剤耐性
  • 市場の機会
    • 新薬とワクチンのパイプラインの拡大
  • 今後の動向
    • 迅速な診断テスト
  • 影響分析

第6章 マラリア治療市場-南米分析

  • 南米のマラリア治療市場の収益予測と分析

第7章 南米のマラリア治療市場分析-治療法別

  • 南米のマラリア治療市場、治療法別2021年・2028年（%）
  • 処方薬
  • ワクチン
  • 診断テスト
  • その他

第8章 南米のマラリア治療市場の分析- 薬剤タイプ別

  • 南米のマラリア治療市場、薬剤タイプ別2021年・2028年（%）
  • ブランド品
  • ジェネリック医薬品

第9章 南米のマラリア治療市場の分析- 投与経路別

  • 南米のマラリア治療市場：投与経路別2021年・2028年（%）
  • 経口投与
  • 非経口・静脈内投与モード

第10章 南米のマラリア治療市場の分析-流通チャネル別

  • 南米のマラリア治療市場：流通チャネル別2021年・2028年（%）
  • 直接入札
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • その他

第11章 南米のマラリア治療薬の市場分析-エンドユーザー別

  • 南米のマラリア治療市場：エンドユーザー別2021年・2028年（%）
  • 病院
  • 専門クリニック
  • ホームケア
  • その他

第12章 南米のマラリア治療市場：国別分析

    • 南米
      • ブラジル
      • アルゼンチン
      • その他の南米地域

第13章 業界情勢

  • 無機的成長戦略
  • 有機的成長戦略

第14章 企業プロファイル

  • Zydus Healthcare Ltd
  • Sun Pharmaceutical Industries Ltd
  • Sanofi SA
  • GSK Plc
  • Novartis AG
  • Cipla Ltd
  • Viatris Inc
  • Lupin Ltd
  • AdvaCare Pharma USA LLC

第15章 付録

図表

List Of Tables

  • Table 1. SAM Malaria Treatment Market - Revenue and Forecast to 2028 (US$ Million)
  • Table 2. Brazil: Malaria Treatment Market, by Treatment- Revenue and Forecast to 2028 (US$ Million)
  • Table 3. Brazil: Malaria Treatment Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 4. Brazil: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
  • Table 5. Brazil: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
  • Table 6. Brazil: Malaria Treatment Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
  • Table 7. Brazil: Malaria Treatment Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 8. Argentina: Malaria Treatment Market, by Treatment- Revenue and Forecast to 2028 (US$ Million)
  • Table 9. Argentina: Malaria Treatment Market, by Prescription Medications - Revenue and Forecast to 2028 (US$ Million)
  • Table 10. Argentina: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
  • Table 11. Argentina: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
  • Table 12. Argentina: Malaria Treatment Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
  • Table 13. Argentina: Malaria Treatment Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 14. Rest of SAM: Malaria Treatment Market, by Treatment- Revenue and Forecast to 2028 (US$ Million)
  • Table 15. Rest of SAM: Malaria Treatment Market, by Prescription Medications - Revenue and Forecast to 2028 (US$ Million)
  • Table 16. Rest of SAM: Malaria Treatment Market, by Drug Type- Revenue and Forecast to 2028 (US$ Million)
  • Table 17. Rest of SAM: Malaria Treatment Market, by Route of Administration- Revenue and Forecast to 2028 (US$ Million)
  • Table 18. Rest of SAM: Malaria Treatment Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
  • Table 19. Rest of SAM: Malaria Treatment Market, by End User- Revenue and Forecast to 2028 (US$ Million)
  • Table 20. Recent Inorganic Growth Strategies
  • Table 21. Recent Organic Growth Strategies in the Malaria Treatment Market
  • Table 22. Glossary of Terms

List Of Figures

  • Figure 1. SAM Malaria Treatment Market Segmentation
  • Figure 2. SAM Malaria Treatment Market Segmentation, By Country
  • Figure 3. SAM Malaria Treatment Market Overview
  • Figure 4. SAM Malaria Treatment Market, By Distribution Channel
  • Figure 5. SAM Malaria Treatment Market, By Country
  • Figure 6. SAM PEST Analysis
  • Figure 7. SAM Malaria Treatment Market impact analysis of driver and restraints
  • Figure 8. SAM Malaria Treatment Market - Revenue Forecast and Analysis
  • Figure 9. SAM Malaria Treatment Market, by Treatment 2021 & 2028 (%)
  • Figure 10. Prescription Medication: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 11. Chloroquine Phosphate: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 12. Artemisinin- based Combination Therapies (ACTs): SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 13. Atovaquone-Proguanil: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 14. Quinine Sulphate (Qualaquin) with Doxycycline: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 15. Primaquine Phosphate: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 16. Others: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 17. Vaccines: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 18. Diagnostic Tests: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 19. Others: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 20. SAM Malaria Treatment Market, by Drug Type 2021 & 2028 (%)
  • Figure 21. Branded: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 22. Generics: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 23. SAM Malaria Treatment Market, by Route of Administration 2021 & 2028 (%)
  • Figure 24. Oral: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 25. Parenteral and Intravenous Mode: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 26. SAM Malaria Treatment Market, by Distribution Channel 2021 & 2028 (%)
  • Figure 27. Direct Tender: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 28. Hospital Pharmacies: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 29. Retail Pharmacies: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 30. Online Pharmacies: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 31. Others: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 32. SAM Malaria Treatment Market, by End User 2021 & 2028 (%)
  • Figure 33. Hospitals: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 34. Specialty Clinics: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 35. Homecare: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 36. Others: SAM Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Mn)
  • Figure 37. SAM: Malaria Treatment Market Revenue Overview, by Country, 2021 (US$ Million)
  • Figure 38. SAM Malaria Treatment Market, by Country, 2021 & 2028 (%)
  • Figure 39. Brazil: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 40. Argentina: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
  • Figure 41. Rest of SAM: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
目次
Product Code: BMIRE00027975

The SAM malaria treatment market is expected to grow from US$ 71.79 million in 2022 to US$ 98.53 million by 2028. It is estimated to register a CAGR of 5.4% from 2022 to 2028.

Rapid Diagnostic Tests is Driving the SAM Malaria Treatment Market

RDTs for malaria can improve the quality of management of the disease. RDTs are proven to be highly affordable and effective for public health programs implemented in low-resource settings. RDTs are widely used in remote areas with limited access to microscopy services. As a result, there has been a rapid rise in the demand for RDTs for malaria. Several RDTs have been developed to test the presence of malaria parasites in blood samples. Identifying and successfully treating malaria in low transmission areas is critical to reduce transmission and achieve complete elimination of the disease. Many companies are engaged in developing a wide range of RDTs with high sensitivities. So, growing rapid diagnostic tests is expected to drive the SAM malaria treatment market growth across the region.

SAM Malaria Treatment Market Overview

The SAM malaria treatment market is categorized into Brazil, Argentina, and the Rest of SAM. Brazil held the substantial share in the market during forecast period. Malaria has always been a major public health concern in Brazil. The early history of malaria in Brazil and measures for its control has been powered by the forced relocation of Africans as enslaved people and the colonization of the Europeans. The immigrants brought malaria to different areas of Brazil. In Brazil, malaria is caused by three species of Plasmodium-P. vivax (which accounts for 83.7% of the registered cases), P. falciparum (causing 16.3% of the cases), and P. malariae (a small proportion of cases). The Brazilian government launched the National Malaria Elimination Plan, intending to reduce the number of local malaria cases to less than 68,000 by 2025 and the number of deaths to zero by 2030, as well as eliminate the disease in Brazil by 2035. Brazil is a country that houses the Amazon rainforest, from where most of the malaria cases come. Approximately 99.9% of transmissions in Brazil occur in the Amazon area and 80% in 33 cities.

In 2021, over 137.8 cases were reported. The Brazilian government is investing in treatment, pest control, and technical support to cities and states while also training personnel. The Elimination Plan will work through the Brazilian Unified Health System, based on free diagnosis and treatment, decentralized actions for diagnostic and wide coverage treatment, and using online information systems, multi-sector partnerships, and research networks. On October 30, 2019, GSK Brazil and MMV announced that the Brazilian Health Regulatory Agency (AVINSA) had granted the Marketing Authorization Approval under propriety review for the single dose tafenoquine for the medical cure of plasmodium vivax malaria in 16-year-old patients and for the older who are receiving chloroquine for the acute P. vivax infection. Jose Carlos Felner, the president of the GSK's pharmaceutical division in Brazil, said that the approval of tafenoquine in the country is an important step in the fight against neglected diseases such as malaria. This will increase the demand for malaria treatment in Brazil and help eradicate the disease. Thus, the growing technical support by the Brazilian government can fuel the growth of the market.

SAM Malaria Treatment Market Revenue and Forecast to 2028 (US$ Million)

SAM Malaria Treatment Market Segmentation

The SAM malaria treatment market is segmented based on treatment, drug type, route of administration, distribution channel, end user, and country.

Based on treatment, the SAM malaria treatment market is segmented into prescription medications, vaccines, diagnostic tests, and others. The diagnostic tests segment held the largest market share in 2022. The prescription medications segment is further categorized into chloroquine phosphate, artemisinin-based combination therapies (ACTs), atovaquone-proguanil, quinine sulfate (qualaquin) with doxycycline, primaquine phosphate, and others.

Based on drug type, the SAM malaria treatment market is bifurcated into branded and generic. The generic segment held a larger market share in 2022.

Based on route of administration, the SAM malaria treatment market is bifurcated into oral and parenteral & intravenous. The oral segment held a larger market share in 2022.

Based on distribution channel, the SAM malaria treatment market is segmented into direct tender, hospital pharmacies, retail pharmacies, online pharmacies, and others. The direct tender segment held the largest market share in 2022.

Based on end user, the SAM malaria treatment market is segmented into hospitals, specialty clinics, homecare, and others. The hospitals segment held the largest market share in 2022.

Based on country, the SAM malaria treatment market has been categorized into Brazil, Argentina, and the Rest of SAM. Our regional analysis states that the Rest of SAM dominated the market in 2022.

AdvaCare Pharma USA LLC, Cipla Ltd, GSK Plc, Lupin Ltd, Novartis AG, Sanofi SA, Sun Pharmaceutical Industries Ltd, Viatris Inc, and Zydus Healthcare Ltd are among the leading companies operating in the SAM malaria treatment market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the SAM malaria treatment market.
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the SAM malaria treatment market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the malaria treatment market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 SAM Malaria Treatment Market - By Treatment
    • 1.3.2 SAM Malaria Treatment Market - By Drug Type
    • 1.3.3 SAM Malaria Treatment Market - By Route of Administration
    • 1.3.4 SAM Malaria Treatment Market - By Distribution Channel
    • 1.3.5 SAM Malaria Treatment Market - By End User
    • 1.3.6 SAM Malaria Treatment Market- By Country

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. SAM Malaria Treatment Market- Market Landscape

  • 4.1 Overview
  • 4.2 SAM PEST Analysis
  • 4.3 Experts Opinion

5. SAM Malaria Treatment Market - Key Market Dynamics

  • 5.1 Market Drivers.
    • 5.1.1 Government and Private Sector's Initiatives to Raise Awareness About Malaria
  • 5.2 Market Restraints
    • 5.2.1 Counterfeit Antimalarial Drugs and Subsequent Drug Resistance
  • 5.3 Market Opportunities
    • 5.3.1 Extending Pipeline of New Drugs and Vaccines
  • 5.4 Future Trends
    • 5.4.1 Rapid Diagnostic Tests
  • 5.5 Impact Analysis

6. Malaria Treatment Market- SAM Analysis

  • 6.1 SAM Malaria Treatment Market Revenue Forecast and Analysis

7. SAM Malaria Treatment Market Analysis - By Treatment

  • 7.1 Overview
  • 7.2 SAM Malaria Treatment Market, By Treatment 2021 & 2028 (%)
  • 7.3 Prescription Medications
    • 7.3.1 Overview
    • 7.3.2 Prescription Medication Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.3 Chloroquine Phosphate
      • 7.3.3.1 Overview
      • 7.3.3.2 Chloroquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.4 Artemisinin- based Combination Therapies (ACTs)
      • 7.3.4.1 Overview
      • 7.3.4.2 Artemisinin- based Combination Therapies (ACTs) Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.5 Atovaquone-Proguanil
      • 7.3.5.1 Overview
      • 7.3.5.2 Atovaquone-Proguanil Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.6 Quinine Sulphate (Qualaquin) with Doxycycline
      • 7.3.6.1 Overview
      • 7.3.6.2 Quinine Sulphate (Qualaquin) with Doxycycline Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.7 Primaquine Phosphate
      • 7.3.7.1 Overview
      • 7.3.7.2 Primaquine Phosphate Market Revenue and Forecast to 2028 (US$ Mn)
    • 7.3.8 Others
      • 7.3.8.1 Overview
      • 7.3.8.2 Others Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.4 Vaccines
    • 7.4.1 Overview
    • 7.4.2 Vaccines Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.5 Diagnostic Tests
    • 7.5.1 Overview
    • 7.5.2 Diagnostic Tests Market Revenue and Forecast to 2028 (US$ Mn)
  • 7.6 Others
    • 7.6.1 Overview
    • 7.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

8. SAM Malaria Treatment Market Analysis - By Drug Type

  • 8.1 Overview
  • 8.2 SAM Malaria Treatment Market, By Drug Type 2021 & 2028 (%)
  • 8.3 Branded
    • 8.3.1 Overview
    • 8.3.2 Branded Market Revenue and Forecast to 2028 (US$ Mn)
  • 8.4 Generics
    • 8.4.1 Overview
    • 8.4.2 Generics Market Revenue and Forecast to 2028 (US$ Mn)

9. SAM Malaria Treatment Market Analysis - By Route of Administration

  • 9.1 Overview
  • 9.2 SAM Malaria Treatment Market, By Route of Administration 2021 & 2028 (%)
  • 9.3 Oral
    • 9.3.1 Overview
    • 9.3.2 Oral Market Revenue and Forecast to 2028 (US$ Mn)
  • 9.4 Parenteral and Intravenous Mode
    • 9.4.1 Overview
    • 9.4.2 Parenteral and Intravenous Mode Market Revenue and Forecast to 2028 (US$ Mn)

10. SAM Malaria Treatment Market Analysis - By Distribution Channel

  • 10.1 Overview
  • 10.2 SAM Malaria Treatment Market, By Distribution Channel 2021 & 2028 (%)
  • 10.3 Direct Tender
    • 10.3.1 Overview
    • 10.3.2 Direct Tender Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.4 Hospital Pharmacies
    • 10.4.1 Overview
    • 10.4.2 Hospital Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.5 Retail Pharmacies
    • 10.5.1 Overview
    • 10.5.2 Retail Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.6 Online Pharmacies
    • 10.6.1 Overview
    • 10.6.2 Online Pharmacies Market Revenue and Forecast to 2028 (US$ Mn)
  • 10.7 Others
    • 10.7.1 Overview
    • 10.7.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

11. SAM Malaria Treatment Market Analysis - By End User

  • 11.1 Overview
  • 11.2 SAM Malaria Treatment Market, By End User 2021 & 2028 (%)
  • 11.3 Hospitals
    • 11.3.1 Overview
    • 11.3.2 Hospitals Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.4 Specialty Clinics
    • 11.4.1 Overview
    • 11.4.2 Specialty Clinics Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.5 Homecare
    • 11.5.1 Overview
    • 11.5.2 Homecare Market Revenue and Forecast to 2028 (US$ Mn)
  • 11.6 Others
    • 11.6.1 Overview
    • 11.6.2 Others Market Revenue and Forecast to 2028 (US$ Mn)

12. SAM Malaria Treatment Market - Country Analysis

  • 12.1 Overview
    • 12.1.1 SAM: Malaria Treatment Market, by Country, 2021 & 2028 (%)
      • 12.1.1.1 Brazil: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.1.1.1.1 Brazil: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.1.1.1.2 Brazil: Malaria Treatment Market, by Treatment, 2019 - 2028 (US$ Million)
        • 12.1.1.1.2.1 Brazil: Malaria Treatment Market, by Prescription medications, 2019 - 2028 (US$ Million)
        • 12.1.1.1.3 Brazil: Malaria Treatment Market, by Drug Type, 2019 - 2028 (US$ Million)
        • 12.1.1.1.4 Brazil: Malaria Treatment Market, by Route of Administration, 2019 - 2028 (US$ Million)
        • 12.1.1.1.5 Brazil: Malaria Treatment Market, by Distribution Channel, 2019 - 2028 (US$ Million)
        • 12.1.1.1.6 Brazil: Malaria Treatment Market, by End User, 2019 - 2028 (US$ Million)
      • 12.1.1.2 Argentina: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.1.1.2.1 Argentina: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.1.1.2.2 Argentina: Malaria Treatment Market, by Treatment, 2019 - 2028 (US$ Million)
        • 12.1.1.2.2.1 Argentina: Malaria Treatment Market, by Prescription Medications, 2019 - 2028 (US$ Million)
        • 12.1.1.2.3 Argentina: Malaria Treatment Market, by Drug Type, 2019 - 2028 (US$ Million)
        • 12.1.1.2.4 Argentina: Malaria Treatment Market, by Route of Administration, 2019 - 2028 (US$ Million)
        • 12.1.1.2.5 Argentina: Malaria Treatment Market, by Distribution Channel, 2019 - 2028 (US$ Million)
        • 12.1.1.2.6 Argentina: Malaria Treatment Market, by End User, 2019 - 2028 (US$ Million)
      • 12.1.1.3 Rest of SAM: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.1.1.3.1 Rest of SAM: Malaria Treatment Market Revenue and Forecasts to 2028 (US$ Million)
        • 12.1.1.3.2 Rest of SAM: Malaria Treatment Market, by Treatment, 2019 - 2028 (US$ Million)
        • 12.1.1.3.2.1 Rest of SAM: Malaria Treatment Market, by Prescription Medications, 2019 - 2028 (US$ Million)
        • 12.1.1.3.3 Rest of SAM: Malaria Treatment Market, by Drug Type, 2019 - 2028 (US$ Million)
        • 12.1.1.3.4 Rest of SAM: Malaria Treatment Market, by Route of Administration, 2019 - 2028 (US$ Million)
        • 12.1.1.3.5 Rest of SAM: Malaria Treatment Market, by Distribution Channel, 2019 - 2028 (US$ Million)
        • 12.1.1.3.6 Rest of SAM: Malaria Treatment Market, by End User, 2019 - 2028 (US$ Million)

13. Industry Landscape

  • 13.1 Overview
  • 13.2 Inorganic Growth Strategies
    • 13.2.1 Overview
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview

14. Company Profiles

  • 14.1 Zydus Healthcare Ltd
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Sun Pharmaceutical Industries Ltd
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Sanofi SA
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 GSK Plc
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Novartis AG
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Cipla Ltd
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Viatris Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Lupin Ltd
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 AdvaCare Pharma USA LLC
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms